Aortic stenosis
MESA study of 6,792 participants over 16.7 years finds a zero aortic valve calcium score beats Lp(a) or LDL-C for ruling out future severe aortic stenosis (Circ Cardiovasc Imaging 2024)
Original title: Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol
Using 6,792 MESA (Multi-Ethnic Study of Atherosclerosis) participants with baseline CT-quantified aortic valve calcium (AVC), Lp(a), and LDL-C from 2000-2002, this study compared which measure best predicted incident severe aortic stenosis over a median 16.7-year follow-up (mean age 62, 47% women). The rate of severe aortic stenosis rose exponentially with higher AVC regardless of Lp(a) or LDL-C level. Participants with AVC of zero had a very low event rate even with elevated Lp(a) (50 mg/dL or above, under 0.1 per 1,000 person-years) or elevated LDL-C (130 mg/dL or above, 0.1 per 1,000 person-years). Conversely, AVC above zero carried a strongly elevated hazard regardless of Lp(a) or LDL-C level (hazard ratios ranging from 31.1 to 61.5 across strata). Aortic valve calcium better identifies people at high risk for severe aortic stenosis than Lp(a) or LDL-C, and a zero AVC score reliably indicates very low long-term risk regardless of lipid levels, a finding useful for selecting participants in future prevention trials.
Original abstract
Background: Aortic valve calcification (AVC), Lp(a) [lipoprotein(a)], and low-density lipoprotein cholesterol (LDL-C) are associated with severe aortic stenosis (AS). We aimed to determine which of these risk factors were most strongly associated with the risk of incident severe AS.
Methods: A total of 6792 participants from the MESA study (Multi-Ethnic Study of Atherosclerosis) had computed tomography-quantified AVC, Lp(a), and LDL-C values at MESA visit 1 (2000-2002). We calculated the absolute event rate of incident adjudicated severe AS per 1000 person-years and performed multivariable adjusted Cox proportional hazards regression.
Results: The mean age was 62 years old, and 47% were women. Over a median 16.7-year follow-up, the rate of incident severe AS increased exponentially with higher AVC, regardless of Lp(a) or LDL-C values. Participants with AVC=0 had a very low rate of severe AS even with elevated Lp(a) ≥50 mg/dL (<0.1/1000 person-years) or LDL-C ≥130 mg/dL (0.1/1000 person-years). AVC >0 was strongly associated with severe AS when Lp(a) <50 mg/dL hazard ratio (HR) of 33.8 (95% CI, 16.4-70.0) or ≥50 mg/dL HR of 61.5 (95% CI, 7.7-494.2) and when LDL-C <130 mg/dL HR of 31.1 (95% CI, 14.4-67.1) or ≥130 mg/dL HR of 50.2 (95% CI, 13.2-191.9).
Conclusions: AVC better identifies people at high risk for severe AS compared with Lp(a) or LDL-C, and people with AVC=0 have a very low long-term rate of severe AS regardless of Lp(a) or LDL-C level. These results suggest AVC should be the preferred prognostic risk marker to identify patients at high risk for severe AS, which may help inform participant selection for future trials testing novel strategies to prevent severe AS.
Summary written by lp-a.org from the published abstract; figures as published. Page updated 18 August 2026. Methods.